NCI announces a course for Oncology Fellows: Translational Research in Clinical Oncology (TRACO)

"Breast Cancer and Genomics" Overview:

by Dr L. Korde, and J. Khan at NIH, NCI

(click above to review a real-time presentation)

Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The Center for Cancer Research (CCR) of the NCI is one of the largest centers for cancer research in the world, with approximately 250 Principal Investigators, and has a major role in development and implementation of many of new technologies, such as genomics and proteomics.

The Translational Research in Clinical Oncology (TRACO) course will be held on Monday afternoons from September to December at the Bethesda Campus, Bldg. 50 ground floor auditorium. TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, mechanisms of resistance, metastasis, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology, meet leaders in cancer research, and interview cancer survivors. The participation of NIH Postdoctoral and Clinical Fellows is encouraged.